Healthcare | July 06, 2022
Apollo Hospitals integrates cardiovascular risk tool with ConnectedLife digital wellness solutions
The AICVD tool can predict the risk of cardiovascular disease.
The AICVD tool can predict the risk of cardiovascular disease.
Vaccizone’s ASC Technology is an enhanced antigen/bioactive delivery method based on Antigen Presenting Cells
Medicines, including insulin, to be available in 40 lower-income countries
The Government of Quebec, through its agent Investissement Quebec, is granting a loan of CAD 25 million
105 million 30 µg, 10 µg and 3 µg doses to be delivered into Q4 2022, with an option for the U.S. Government to purchase up to 195 million additional doses
The over-the-counter market has long been an important segment of Glenmark’s portfolio around the world
The research here will mainly concentrate on the manufacturing process of biopharmaceuticals, especially in the area of advanced medicines, as well as the fermentation-based manufacture of ingredients for foods and food supplements
Strengthens investment in channels of the future to expand patient reach
Silo enters into commercial evaluation license agreement for next generation liposomes
An interim analysis of this data shows no significant safety issues and a 91% seroconversion rate at Day 56.
Subscribe To Our Newsletter & Stay Updated
